In summary, our data suggest that upregulation of SNAI2 and possibly partial EMT could contribute to the progressive kidney phenotype observed in Lowe syndrome and Dent II disease; however, confirmation of these results in animal model systems and Lowe syndrome/Dent II disease patients is necessary. Here, SNAI2 is linked to oculocerebrorenal syndrome.